Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)

NCT01305746 is registered in ClinicalTrials.gov with Anthera Pharmaceuticals as lead sponsor.

NCT NCT01305746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01305746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Long-term Safety Extension Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC)
Lead sponsor
Anthera Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2011
Completion date
October 31, 2013
Enrollment
382 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus